University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) — Birmingham, Alabama

University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) is a clinical research site located in Birmingham, Alabama, United States 35233.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) has participated in 1 clinical trials.

Therapeutic areas: Brain Metastases, Small Cell Lung Cancer.

Sponsors: Drexell Hunter Boggs.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC)?

University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) conducted?

University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) has 1 clinical trials on record. Their work covers Brain Metastases, Small Cell Lung Cancer.

Is University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) accredited by Crixeo Health?

University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham (UAB), Hazelrig-Salter Radiation Oncology Center (HSROC)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.